» Articles » PMID: 20699379

Expression of the Tumor Suppressor Krüppel-like Factor 4 As a Prognostic Predictor for Colon Cancer

Overview
Date 2010 Aug 12
PMID 20699379
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The zinc finger transcription factor Krüppel-like factor 4 (KLF4) regulates numerous physiologic processes, including proliferation, differentiation, and development. Studies also showed that KLF4 is involved in tumorigenesis and somatic cell reprogramming. Here, we aimed to assess whether KLF4 is a prognostic indicator for colon cancer.

Methods: Levels of KLF4 were measured by immunohistochemical analysis of a tissue microarray containing 367 independent colon cancer sections. Univariate data analysis was done in addition to construction of multivariate models with several clinicopathologic factors to evaluate KLF4 as an independent predictor of survival and cancer recurrence (disease-free survival).

Results: Colon cancer tissues had significantly overall lower KLF4 levels compared with noncancer tissues (P < 0.0001). Using logistic regression, a trend was noted for decreased odds of KLF4 expression in higher stages of tumors. In univariate and multivariate analyses, KLF4 was a significant predictor of survival and recurrence.

Conclusions: KLF4 expression is significantly downregulated in colon cancer, and loss of KLF4 is an independent predictor of survival and recurrence.

Impact: These findings suggest that KLF4 may serve as a prognostic biomarker for colon cancer.

Citing Articles

KLF4 suppresses the proliferation of perihilar cholangiocarcinoma by negatively regulating GDF15 and phosphorylating AKT.

Zhang X, Wang W, Lu C, Zhang H Oncol Rep. 2023; 50(6).

PMID: 37937607 PMC: 10652240. DOI: 10.3892/or.2023.8659.


Krüppel-like Factors 4 and 5 in Colorectal Tumorigenesis.

Lee E, Cheung J, Bialkowska A Cancers (Basel). 2023; 15(9).

PMID: 37173904 PMC: 10177156. DOI: 10.3390/cancers15092430.


Necrosis score as a prognostic factor in stage I-III colorectal cancer: a retrospective multicenter study.

Ye H, Wang Y, Yao S, Liu Z, Liang C, Zhu Y Discov Oncol. 2023; 14(1):61.

PMID: 37155090 PMC: 10167085. DOI: 10.1007/s12672-023-00655-w.


SP and KLF Transcription Factors in Cancer Metabolism.

Orzechowska-Licari E, LaComb J, Mojumdar A, Bialkowska A Int J Mol Sci. 2022; 23(17).

PMID: 36077352 PMC: 9456310. DOI: 10.3390/ijms23179956.


Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application.

Saito S, Ku C, Wuputra K, Pan J, Lin C, Lin Y J Pers Med. 2022; 12(5).

PMID: 35629138 PMC: 9147761. DOI: 10.3390/jpm12050715.


References
1.
Yoon H, Yang V . Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem. 2003; 279(6):5035-41. PMC: 1262649. DOI: 10.1074/jbc.M307631200. View

2.
Cho Y, Song J, Kim C, Nam S, Yoo N, Lee J . Genetic and epigenetic analysis of the KLF4 gene in gastric cancer. APMIS. 2007; 115(7):802-8. DOI: 10.1111/j.1600-0463.2007.apm_643.x. View

3.
Ghaleb A, Aggarwal G, Bialkowska A, Nandan M, Yang V . Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium. Mol Cancer Res. 2008; 6(12):1920-7. PMC: 2628949. DOI: 10.1158/1541-7786.MCR-08-0224. View

4.
Sjoblom T, Jones S, Wood L, Parsons D, Lin J, Barber T . The consensus coding sequences of human breast and colorectal cancers. Science. 2006; 314(5797):268-74. DOI: 10.1126/science.1133427. View

5.
Ohnishi S, Ohnami S, Laub F, Aoki K, Suzuki K, Kanai Y . Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun. 2003; 308(2):251-6. DOI: 10.1016/s0006-291x(03)01356-1. View